Amazon personalizes Prime Video ads: Dynamic TV Creative tailors repeat spots using shopping data, turning CTV reach into retail action.
TikTok tests paid ad-free model in UK: While ad revenues remain stable, creator deals could gain value if subscription adoption climbs.
IHeartMedia earnings show the power of podcasts: Though the format has its challenges, strong growth will make it a priority for audio platforms.
44% of US college sports fans say sponsorship influences their purchase decisions, including 14% who actively prioritize sponsored brands, according to a February study from Big Chalk.
Rising prices drive consumers to use credit cards and BNPL to make ends meet.
Although the US economy is facing hard financial times due to rising gas prices and other headwinds, consumers expect to up their spending this summer, according to a Spring 2026 survey by Optimove Research.
TikTok turns travel inspiration into bookings: Hotel and experience booking tests a super app model that blends content, commerce, and commission.
Ultra-fast delivery widens the retailer’s grocery edge and raises stakes for rivals, as well as Instacart and DoorDash.
OpenAI experiments with feed ads: Beta tool converts retail catalogs into ChatGPT ads, linking spend to intent-driven chats.
Troubled user experience dogged the platform, but helpful tabs and new features could streamline the app.
Both Google Pay and the BNPL firms may get a lift from AI- and installment-eager Gen Zers.
Shipping stress nears pandemic highs as fuel spikes squeeze profits and dent demand.
Traffic rises across formats as young shoppers seek social hubs and in-store discovery.
A direct mail expert identifies optimization opportunities for banks’ direct mail programs.
They’re deploying agentic AI with the help of fintech partnerships.
Banks that meet customers where they are can boost satisfaction and loyalty.
Yet many consumers still engage with their content, pushing marketers to ensure their influencer partners have credibility.
Telehealth firms switching from compounded to brand-name GLP-1s must offer stronger patient support and expand into other high-demand treatments, like hormone therapies.
The medical society is proposing policies around bans, labels, and consent rules as fake physicians erode trust and risk patient harm.